PMID: 2496425Jan 1, 1989Paper

Development and loss of tolerance to the effects of ethanol on DRL performance of rats

Psychopharmacology
D C Bird, F A Holloway

Abstract

Six male Sprague-Dawley rats were trained on a DRL-20 operant schedule for food presentation. When stable performance was established, they were exposed to an escalating regimen of daily ethanol administration (1.125-3.75 g/kg, IP). This dosing regimen continued until the maximally tolerable dose for each subject was reached. Tolerance loss then was monitored for approximately 6 months by periodic ethanol challenge doses (1.5 g/kg). Dose-effect curves (DECs) were obtained prior to (DEC-1), immediately after (DEC-2), and 6 months following termination of (DEC-3) the ethanol exposure. Rate-increasing effects (DEC-1) were noted at low doses (0.75 and 1.125 g/kg), with a higher dose (2.25 g/kg) resulting in a decreased rate of responding. Tolerance, following chronic ethanol exposure, developed to both the rate-increasing and rate-decreasing effects of ethanol (DEC-2). While some tolerance was lost within the 6 months following the daily ethanol exposure (DEC-3), a significant degree of tolerance was still indicated by most of the response measures. This duration of tolerance was considerably longer than that generally reported, and is probably attributable to persistent learned compensatory behavior and/or intermittent ethanol cha...Continue Reading

References

Jan 1, 1979·Drug and Alcohol Dependence·H Cappell, A E LeBlanc
Jul 28, 1976·Psychopharmacology·A E LeblancR J Gibbins
Jan 1, 1975·Psychopharmacologia·A E LeBlancR J Gibbins
May 28, 1976·Psychopharmacologia·J D LeanderF W Ellis
Jan 1, 1988·Pharmacology, Biochemistry, and Behavior·F A HollowayR C Michaelis
Jan 1, 1966·Psychopharmacologia·C R SchusterJ H Woods
Feb 1, 1962·Journal of Comparative and Physiological Psychology·V G LATIES, B WEISS

❮ Previous
Next ❯

Citations

Jan 1, 1989·Psychopharmacology·F A HollowayD C Bird
Jan 1, 1990·Psychopharmacology·E McElroy, A Neuringer
Dec 1, 1989·Pharmacology, Biochemistry, and Behavior·F A Holloway, D A King
Dec 4, 2004·Behavioural Pharmacology·J Abreu-RodriguesZ Delabrida
Dec 23, 2008·Journal of Neurogenetics·Henrike Scholz
Jul 1, 1990·Journal of the Experimental Analysis of Behavior·L CohenD Rhodes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.